THOMAS YATES: Open Payments
NPI 1225012446 · TOCCOA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,022 in 48 payments from 17 companies in 2025. Trend: 2023 $1,480 · 2024 $1,081 · 2025 $1,022
Food & beverage: $1,022
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $305 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $114 |
| Indivior Inc. | 7 | $112 |
| AstraZeneca Pharmaceuticals LP | 4 | $85 |
| ABBVIE INC. | 4 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
| PFIZER INC. | 4 | $61 |
| Calliditas Therapeutics US Inc. | 1 | $36 |
| Eisai Inc. | 1 | $31 |
| Braeburn Inc. | 1 | $30 |
Products named: Wegovy, Rybelsus, JARDIANCE, SUBLOCADE, FARXIGA, Kerendia, ELIQUIS, Ozempic.
Industry payments across GA — which companies pay providers there.
